CVS Health (NYSE:CVS) has had a great fourth quarter of 2014, beating the market expectations and earning the investor’s respect. In a turbulent health market, CVS Health (NYSE:CVS)held its ground and made positive earnings amidst speculations and presumptions regarding the company’s stock plunging in near future. But that hasn’t been the case. CVS Health (NYSE:CVS) has emerged as a winner. CVS Health (NYSE:CVS) made $2.9 billion in the fourth quarter of 2014 and that added to the total year earnings, making it $6.5 billion. For a pharmacy retailer to earn that much is commendable.

CVS Health (NYSE:CVS) has been raging because of the specialty drugs, thanks to high end pharmaceutical companies like Gilead Sciences (NASDAQ:GILD) and its Hepatitis C drugs which are highly in demand. The sales made off of those drugs contributed to a chunk of CVS Health (NYSE:CVS)’s fourth quarter earnings. Here we mustn’t forget that it hasn’t just been the specialty drugs but the normal every-day drugs were also in demand and CVS Health (NYSE:CVS) made a fortune off of that, making billions in one year, which is unlikely for a pharmaceutical company.

CVS Health (NYSE:CVS) decision to take the no tobacco road must have been hard on the finances but not too hard. In fact, in public the decision was applauded and the sales have been stable, unlike what the analysts were predicting. It was forecasted that dropping tobacco off of its products will hurt the sales of the company. The sales have lowered down but only by a small margin which will be easily compensated in the coming times. The drugs being rolled out by large end companies, especially the specialty drugs, will land in CVS Health (NYSE:CVS). The more a company manufactures drugs, the more profit CVS Health (NYSE:CVS) can expect.

The management of the company has said that their guidance for 2015 looks extremely positive and now would be the ideal time for investors to come on board and get healthy returns, because you never know what goes on in the health sector and a stock soaring today might be beneath the ground tomorrow. In any case, CVS Health (NYSE:CVS) is a healthy buy and as an investor, the stock should definitely interest you.

Another great thing about CVS Health (NYSE:CVS) is that it has been making billions while the market was writing it off and investing against it. The company proved everyone wrong and came out with a profit of billions and now the investors are coming onboard one by one. It’s a good sign for the retailer because investors will help the company in dire situations that are bound to come in the health market.

One must realize that the turbulent health market isn’t a guaranteed option ever. If the pharmaceutical companies don’t do business, CVS Health (NYSE:CVS) won’t do business either because there will be no drugs to sell. So let’s hope the healthcare industry remains stable so CVS Health (NYSE:CVS) remains stable as well.

The pharmacy and retail chain unveiled its new name yesterday, which was also the day that the drugstore made its last sale of tobacco products at all of its 7,700 pharmacies. Its purge of tobacco products ended a whole month ahead of schedule. CVS said in February that it would get rid of all of the tobacco products in its stores by the 1^st of October. This move meant that the company would have to give up about $2 billion in sales each year.

The financial risk that the company was taking on was justified by the hope that being the fire major pharmacy chain to cease to sell tobacco products would place a halo around its head in terms of public relations. CVS is dependent on the hope that the distinction will help it gain traffic and customers in other parts of the company, such as the market of prescription drug programs for clients. The company also hopes that this move will reposition it as a larger provider with a wider range of basic services regarding health care.

Larry Merlo, the president and chief executive officer of CVS said in an interview that while there is never a correct time to walk away from $2 billion in revenue, this was the right time. Eliminating the obstacle of tobacco products will enable the company to grow over the long term.

It is not clear whether the decision has resulted in any financial benefits to the pharmacy chain. No other national pharmacy chain has followed in CVS’s footsteps to get rid of cigarettes.

Walgreen Co (NYSE:WAG), the biggest pharmacy chain in the United States, stated that only 4 percent of tobacco products are sold at pharmacies. The company believes that dropping tobacco products from its stores will have a negligible effect on cigarette use, since smokers can go to other vendors like dollar stores, which now carry cigarettes in recent years. As Walgreens continues to sell cigarettes and other tobacco products, Walgreens said that it will emphasize its offering of other products and programs to help people quit smoking.

In a study that was published yesterday, both San Francisco and Boston had banned tobacco sales at retailers with pharmacies, and the result was that the number of people buying tobacco dropped by 13.3 percent. This shows that a widespread effort is more effective at reducing cigarette sales and thus cigarette usage.

CVS said that it plans to use the space once occupied by tobacco products behind the check out registers to advertise the fact that they do not sell the product anymore. The president of the pharmacy division of CVS, Helena Foulkes, stated that some of that space will also be used to stock products that will help smokers quit.

CVS also noted that they do not plan to carry electronic cigarettes. According to Mr. Merlo, the company does not believe that it is consistent with everything that the company has taken measures to do.

CVS Caremark Corporation (NYSE:CVS) today announced that it has been awarded a three-year contract to provide integrated pharmacy benefit services for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program (FEP). CVS Caremark Corporation (NYSE:CVS) in last trading activity ended up at $75.30 with day range of $75.12 – $76.36. Company weekly performance is 2.44% while its quarterly performance stands at 7.22%.CVS Caremark Corporation (NYSE:CVS) is 0.33% away from its 52 week high.

BB&T Corporation (NYSE:BBT) successful weathering of the most recent round of stress tests by bank regulators had led the Federal Reserve to OK its plans for how it will use its capital. BB&T Corporation (NYSE:BBT) belongs to Financial sector with market capitalization of 28.59 billion and has 0.50% insider ownership. In last trading activity company’s stock closed at $40.53 while opening price was $40.80.

Palo Alto, CA based Hewlett-Packard (NYSE:HPQ) Enterprise Services has announced a new service designed to help accelerate the U.S. public sector’s adoption of mobile technology to drive workforce productivity while securing IT assets. On Wednesday shares of Hewlett-Packard Company (NYSE:HPQ) opened at $32.77 and closed at $32.35. This year Company’s Earnings per Share (EPS) growth is 2.73 and next year’s estimated EPS growth is 3.59%. Analysts mean target price for Hewlett-Packard Company (NYSE:HPQ) is $32.44.

Sonic (NASDAQ:SONC) was having its best day in years Tuesday after the drive-in chain got past analysts’ earnings targets and retained its profit goals for the current year, but its value was reaching rarefied air as a result. Sonic Corporation (NASDAQ:SONC) in last trading activity ended up at $23.23 with day range of $22.30 – $23.51. Company weekly performance is 4.12% while its quarterly performance stands at 11.31%.Sonic Corporation (NASDAQ:SONC) is 3.89% away from its 52 week high.

Brocade Communications Systems (NASDAQ:BRCD) VP Ken Cheng unloaded 15,000 shares of Brocade Communications Systems stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $10.35, for a total transaction of $155,250.00. Following the completion of the sale, the vice president now directly owns 292,625 shares of the company’s stock, valued at approximately $3,028,669. Brocade Communications Systems, Inc. (NASDAQ:BRCD) belongs to Technology sector with market capitalization of 4.61 billion and has 0.20% insider ownership. In last trading activity company’s stock closed at $10.46 while opening price was $10.27.

CVS Caremark Corporation (NYSE:CVS) and Veterans Advantage Inc. yesterday announced an exclusive new 20% discount program both in-store and online for Veterans Advantage’s VetRewards Card members. Valid at any of CVS/pharmacy’s 7,600 stores nationwide, or at CVS.com, U.S. Active Duty Military, Veterans, National Guard & Reserve and their families can save 20% off purchases and receive free shipping for online orders. On Tuesday shares of CVS Caremark Corporation (NYSE:CVS) opened at $74.72 and closed at $74.95. This year Company’s Earnings per Share (EPS) growth is 3.76 and next year’s estimated EPS growth is 12.09%. Analysts mean target price for CVS Caremark Corporation (NYSE:CVS) is $77.04.